期刊文献+

舌癌组织中p53和c-myc的表达及端粒酶活性的实验研究 被引量:1

The Experimental Study on Telomerase Activity and Expression of p53 and c-myc Genes in Tongue Cancer
暂未订购
导出
摘要 目的 探讨端粒酶和原癌基因c_myc和p5 3在舌癌组织中的表达以及相互作用 ,分析它们与舌癌组织临床病理特征之间的可能关系。方法 采用原位杂交技术和端粒末端重复放大技术 (TRAP)分别检测c_myc和p5 3在舌癌组织中的表达以及舌癌组织中端粒酶的活性。结果 在低分化的舌癌组织中端粒酶活性明显升高(P <0 0 5 ) ,c_myc在低分化 1级舌癌组织中阳性表达显著升高 (P <0 0 5 ) ;p5 3在舌癌伴淋巴结转移患者中阳性表达明显降低 (P <0 0 5 )。结论 端粒酶在舌癌的发生发展过程中可能起重要作用 ,c_myc和p5 3在舌癌发生过程中对端粒酶的激活发挥重要影响。 Objective To study telomerase activity and expression of oncogenes c-myc and p53 in tongue cancer, analyse the interaction among them, and assess their possible correlations with tongue cancer clinicopathological features.Methods To detective the telomerase activity by TRAP and examine the positive expression of c-myc and p53 in tongue cancer by hybridization in situ.Results A high telomerase activity existed in lower differentiated tongue cancer (P<0.05); the positive expression of c-myc increased significantly in lower grade tongue cancer (P<0.05) and the positive expression of p53 decreased increasingly in tongue cancer accompanied with lymph node metastasis (P<0.05).Conclusion Telomerase may play a key role in the tumorigenesis of tongue cancer. Meantime, c-myc and p53 exerts important effect on telomerase activation during the course of tongue cancer generation and development.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2003年第4期274-276,共3页 West China Journal of Stomatology
基金 国家自然科学基金青年基金资助项目 (编号 3990 0 0 36)
关键词 舌癌组织 P53 C-MYC 表达 端粒酶 活性 实验研究 telomerase c-myc p53 tongue cancer hybridization in situ
  • 相关文献

参考文献12

  • 1Chadeneau C, Hay K, Hirte HW, et al. Telomerase activity associated with acquisition of malignancy in human colorectal cancer.Cancer Res, 1995,55(12) :2533-2536.
  • 2Greenblatt MS, Bennt P, Hollstein M, et al. Mutation in the p53 tumor suppressor gene: Clue to cancer etiology and molecular pathogenesis. Cancer Res, 1994,54(18) :4855-4878.
  • 3Fanidi A, Harrington EA, Evan GI. Cooperation interaction between c-myc and p53 proto-oncogenes. Nature, 1992,359 (6395) :554-556.
  • 4Gueider CW, Blackburn EH. The telomere terminal transferase of Tetrahymena: A ribonudeoprotein enzyme with two kinds of primer specificity. Cell, 1987,51(6) :887-898.
  • 5Shay JW,Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer, 1997,33 (5):787.
  • 6Crocker J. Telomeres and telomerases: Intimations of immortality.Eur J Gastroenterol Hepatol, 2001,13 (8) :889-890.
  • 7Rhyu MS. Telomeres, teloraerase and immortality. J Nail Cancer Inst, 1995,87(12) :884-894.
  • 8Drissi R, Zindy F, Roussel MF, et al. C-myc-mediated regulation of telomerase activity is disabled in immortalized cells. J Biol Chem, 2001,276(32) :29994-30001.
  • 9Sakanmro D, Eviner V, Elliott JK, et al. C-myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene, 1995,11(11):2411-2418.
  • 10Wu X, Kemp B, Amos CI, et al. Association among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer. Br J Cancer, 1999,80(3-4) :453-457.

同被引文献17

  • 1Mahmoudi S, Henriksson S, Farnebo L, et al. WRAP53 promotes cancer cell survival and is a potential target for cancer therapy[J]. Cell Death Dis, 2011, 2:e1 14.
  • 2Mahmoudi S, Henriksson S, Corcoran M, et al. Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage[J]. Mol Cell, 2009, 33(4):462-471.
  • 3Famebo M, Bykov VJ, Wiman KG. The p53 tumor suppressor: a master regulator of diverse cellular processes and chem Biophys therapeutic target in cancer[J]. Bio- Res Commun, 2010, 396(1):85-89.
  • 4Yuan JM, Li XD, Liu ZY, et al. Cisplatin induces apoptosis via upregulating Wrap53 in U-2OS os- teosarcoma cells[J]. Asian Pac J Cancer Prev, 2011, 12(12):3465-3469.
  • 5Farnebo M. Wrap53, a novel regulator of p53[J]. Cell Cycle, 2009, 8(15):2343-2346.
  • 6Saldafia-Meyer R, Recillas-Targa F. Transcriptionaland epigenetic regulation of the p53 tumor sup- pressor gene[J]. Epigenetics, 2011, 6(9): 1068-1077.
  • 7Venteicher AS, Abreu EB, Meng Z, et al. A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis[J]. Science, 2009, 323(5914):644-648.
  • 8Stern JL, Zyner KG, Pickett HA, et al. Telomerase recruitment requires both TCAB1 and Cajal bodies independently[J]. Mol Cell Biol, 2012, 32(13):2384- 2395.
  • 9Mahmoudi S, Henriksson S, Weibrecht I, et al. WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies[J]. PLoS Biol, 2010, 8(11):e1000521.
  • 10Lee JH, Lee YS, Jeong SA, et al. Catalytically active telomerase holoenzyme is assembled in the dense fibrillar component of the nucleolus during S phase [J]. Histochem Cell Biol, 2014, 141(2):137-152.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部